A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.
Clinical trial NCT01899755 · COMPLETED
Trial details
- NCT number
- NCT01899755
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-10
- Primary completion
- 2014-04-03
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.